These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 7478124

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
    Lehto JT, Lemström K, Halme M, Lappalainen M, Lommi J, Sipponen J, Harjula A, Tukiainen P, Koskinen PK.
    Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
    [Abstract] [Full Text] [Related]

  • 4. A prospective study of the predictive value of polymerase chain reaction assay for cytomegalovirus in asymptomatic kidney transplant recipients.
    Benedetti E, Mihalov M, Asolati M, Kirby J, Dunn T, Raofi V, Fontaine M, Pollak R.
    Clin Transplant; 1998 Oct; 12(5):391-5. PubMed ID: 9787946
    [Abstract] [Full Text] [Related]

  • 5. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.
    Matsunaga T, Sakamaki S, Ishigaki S, Kohda K, Takeda M, Katoh J, Kuroda H, Hirayama Y, Kusakabe T, Akiyama T, Kuga T, Niitsu Y, Masaoka T, Sagawa T, Matsumoto Y.
    Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460
    [Abstract] [Full Text] [Related]

  • 6. High frequency of positive surveillance for cytomegalovirus (CMV) by PCR in allograft recipients at low risk of CMV.
    Butt NM, Clark RE.
    Bone Marrow Transplant; 2001 Mar; 27(6):615-9. PubMed ID: 11319591
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Hebart H, Rudolph T, Loeffler J, Middeldorp J, Ljubicic T, Jahn G, Einsele H.
    Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
    [Abstract] [Full Text] [Related]

  • 8. Rapid detection cytomegalovirus pneumonia in recipients of bone marrow transplant: evaluation and comparison of five survey methods for bronchoalveolar lavage fluid.
    Goto H, Yuasa K, Sakamaki H, Nakata K, Komuro I, Iguchi M, Okamura T, Ieki R, Tanikawa S, Akiyama H, Onozawa Y, Mochida Y.
    Bone Marrow Transplant; 1996 May; 17(5):855-60. PubMed ID: 8733709
    [Abstract] [Full Text] [Related]

  • 9. "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?
    Osman HK, Peiris JS, Taylor CE, Warwicker P, Jarrett RF, Madeley CR.
    J Med Virol; 1996 Apr; 48(4):295-301. PubMed ID: 8699160
    [Abstract] [Full Text] [Related]

  • 10. [The polymerase chain reaction as a marker of cytomegalovirus infection in heart transplant recipients].
    Niubò J, Pérez JL, Manito N, García A, Roca J, Martín R.
    Med Clin (Barc); 1999 Feb 06; 112(4):121-4. PubMed ID: 10074629
    [Abstract] [Full Text] [Related]

  • 11. A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival.
    Eriksson BM, Wirgart BZ, Claesson K, Tufveson G, Magnusson G, Tötterman T, Grillner L.
    Clin Transplant; 1996 Dec 06; 10(6 Pt 1):494-502. PubMed ID: 8996769
    [Abstract] [Full Text] [Related]

  • 12. Dynamics of cytomegalovirus (CMV) plasma DNAemia in initial and recurrent episodes of active CMV infection in the allogeneic stem cell transplantation setting: implications for designing preemptive antiviral therapy strategies.
    Muñoz-Cobo B, Solano C, Costa E, Bravo D, Clari MÁ, Benet I, Remigia MJ, Montoro J, Navarro D.
    Biol Blood Marrow Transplant; 2011 Nov 06; 17(11):1602-11. PubMed ID: 21871245
    [Abstract] [Full Text] [Related]

  • 13. Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
    Peggs KS, Preiser W, Kottaridis PD, McKeag N, Brink NS, Tedder RS, Goldstone AH, Linch DC, Mackinnon S.
    Br J Haematol; 2000 Dec 06; 111(3):782-90. PubMed ID: 11122138
    [Abstract] [Full Text] [Related]

  • 14. Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG).
    Hassan-Walker AF, Kidd IM, Sabin C, Sweny P, Griffiths PD, Emery VC.
    J Med Virol; 1999 Jun 06; 58(2):182-7. PubMed ID: 10335868
    [Abstract] [Full Text] [Related]

  • 15. Clinical and practical value of human cytomegalovirus DNAemia detection by semi-nested PCR for follow-up of BMT recipients.
    Imbert-Marcille BM, Milpied N, Coste-Burel M, Richet B, Moreau P, Harousseau JL, Billaudel S.
    Bone Marrow Transplant; 1995 Apr 06; 15(4):611-7. PubMed ID: 7655389
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
    Piiparinen H, Helanterä I, Lappalainen M, Suni J, Koskinen P, Grönhagen-Riska C, Lautenschlager I.
    J Med Virol; 2005 Jul 06; 76(3):367-72. PubMed ID: 15902704
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.